熱門資訊> 正文

ANI Pharmaceuticals 2026年第二季度盈利预览

2026-08-06 21:21

ANI Pharmaceuticals(ANIP) 0

ANI Pharmaceuticals (ANIP) is scheduled to announce Q2 earnings results on Friday, August 7th, before market open.
The consensus EPS Estimate is $2.04 (+13.3% Y/Y) and the consensus Revenue Estimate is $260.13M (+23.1% Y/Y).
Over the last 2 years, ANIP has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time.
Over the last 3 months, EPS estimates have seen 1 upward revision and 6 downward. Revenue estimates have seen 4 upward revisions and 2 downward.

More on ANI Pharmaceuticals

ANI Pharmaceuticals: The Market Is Pricing The Present, Not The Future
ANI Pharmaceuticals: Rare Disease Growth At A Generics Multiple
ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call Transcript
ANI Pharmaceuticals raises 2026 revenue outlook to $1.08B-$1.14B while launching $100M share repurchase program
Seeking Alpha’s Quant Rating on ANI Pharmaceuticals

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。